The Latest in Follicular Lymphoma

Novel SYK inhibitor shows ‘good early evidence’ of activity

July 5, 2015

Follicular Lymphoma

Early relapse signals high mortality in follicular lymphoma

July 2, 2015

Follicular Lymphoma

‘Radically different’ PI3Kδ inhibitor lacks hepatotoxicity

June 30, 2015

Follicular Lymphoma

P13K inhibitors TGR-1202, duvelisib found clinically active in CLL

June 26, 2015

Follicular Lymphoma

Targeted agent shows early promise for NHL

June 25, 2015

Follicular Lymphoma

EZH2 inhibitor proves active in rel/ref NHL

June 23, 2015

Follicular Lymphoma

CAR T-cell therapy seems feasible for NHL, MM

June 11, 2015

Follicular Lymphoma

Prenatal test can detect lymphoma in mothers

June 8, 2015

Follicular Lymphoma

Drug prolongs PFS in indolent, refractory NHL

June 2, 2015

Follicular Lymphoma

GADOLIN: Combination improves PFS in rituximab-refractory indolent NHL

May 30, 2015

Follicular Lymphoma

Susceptibility to 2nd cancers in WM/LPL survivors

April 30, 2015

Follicular Lymphoma

Inhibitor gets orphan designation for DLBCL

April 8, 2015

Follicular Lymphoma

Vitamin D levels linked to outcomes in FL

April 1, 2015

Follicular Lymphoma

Pesticides may cause NHL, other cancers

March 25, 2015

Follicular Lymphoma

Maintenance prolongs PFS, not OS, in relapsed CLL

January 7, 2015

Follicular Lymphoma